Unverified50% confidenceFactExact time
KRISHOKTECH's dosage verifier adopts a narrow-scope design that targets only dosage claims and does not cover other types of errors such as crop disease identification errors or deviations in application timing advice.
1
Sources
50%
Confidence
Long-term
Relevance
10/26/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedWhen the sample size is limited, k-fold cross-validation is usually needed rather than a single training/test split, to reduce the variance of evaluation results.67% similarUnverifiedThe paper proves finite-time guarantees for policy evaluation and sparse sampling, with estimation error independent of the risk level.64% similarUnverifiedAlphaFold lowered the barrier to early target assessment and structure-based drug design, but it provides structural hypotheses rather than biological validation; predicted structures still require experimental confirmation and cannot replace functional experiments and preclinical toxicology assessments.63% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1098375API
curl https://kongchang.com/api/v1/knowledge/claims/1098375MCP
get_claim(id=1098375)